DDInter1084 DDInter1082
Lomefloxacin is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Lomefloxacin {u} (Compound) resembles {v} (Compound) Sparfloxacin
Lomefloxacin {u} (Compound) resembles {v} (Compound) Moxifloxacin
Lomefloxacin {u} (Compound) binds {v} (Gene) TOP2A
Lomefloxacin {u} (Compound) causes {v} (Side Effect) Potassium low
Lomefloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Daunorubicin
Lomefloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cytarabine
Lomefloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Bisacodyl
Lomefloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methoxsalen
Lomefloxacin {u} may lead to a major life threatening interaction when taken with {v} Methylprednisolone
Lomefloxacin {u} may lead to a major life threatening interaction when taken with {v} Ivosidenib
Lomefloxacin (Compound) resembles Sparfloxacin (Compound)
Lomefloxacin (Compound) resembles Moxifloxacin (Compound)
Lomefloxacin (Compound) binds TOP2A (Gene)
Lomefloxacin (Compound) causes Potassium low (Side Effect)
Lomefloxacin may cause a minor interaction that can limit clinical effects when taken with Daunorubicin
Lomefloxacin may cause a minor interaction that can limit clinical effects when taken with Cytarabine
Lomefloxacin may cause a moderate interaction that could exacerbate diseases when taken with Bisacodyl
Lomefloxacin may cause a moderate interaction that could exacerbate diseases when taken with Methoxsalen
Lomefloxacin may lead to a major life threatening interaction when taken with Methylprednisolone
Lomefloxacin may lead to a major life threatening interaction when taken with Ivosidenib